Cupid Ltd.
Research Cupid Ltd. (CUPID.NS) on Bullrun: market cap INR 475.61B, P/E 353.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCUPID.NS
- ExchangeNSE
- CountryIndia
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyINR
- Market capINR 475.61B
- P/E353.7
- Financial periodQ2 2026
- RevenueINR 1.55B
- Net incomeINR 441.49M
- Gross margin58.1%
Valuation Snapshot
latest market cap is INR 475.61B; P/E is 353.7.
Peer valuation comparison
Latest P/E is 353.7x versus a Consumer Defensive sector median of 16.8x (2005.2% above).
Latest P/E is 353.7x versus a India median of 34.43x (927.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 475.61B | 353.7 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 INR.
About Cupid Ltd.
Cupid Limited manufactures and supplies male and female condoms in India and internationally. The company offers water based lubricant jellies; in vitro diagnostic kits, including viral transport medium, pregnancy detection testing kit, ovulation testing kit, typhoid antibody, dengue, hepatitis b antigen, malaria antigen, syphilis antibody, hepatitis C, HIV/Syphilis Combo, rapid diagnostic, HIV 1 and 2 kit antibody testing kits, as well as COVID-19 antigen tests;
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Cupid Ltd.'s market cap?
Cupid Ltd.'s market capitalization is INR 475.61B.
What is Cupid Ltd.'s P/E ratio?
Cupid Ltd.'s price-to-earnings (P/E) ratio is 353.7.
What does Cupid Ltd. do?
Cupid Limited manufactures and supplies male and female condoms in India and internationally. The company offers water based lubricant jellies; in vitro diagnostic kits, including viral transport medium, pregnancy detection testing kit, ovulation testing kit, typhoid antibody, dengue, hepatitis b antigen, malaria antigen, syphilis antibody, hepatitis C, HIV/Syphilis Combo, rapid diagnostic, HIV 1 and 2 kit antibody testing kits, as well as COVID-19 antigen tests; and FMCG, personal care, and wellness products including deodorants, perfumes, face wash, hair-removal sprays, hair and body oils,.